Desperately seeking Sigma

A merger of the two publicly listed pharmacy wholesalers, Australian Pharmaceutical Industries (API) and Sigma Healthcare, has been on the cards for almost two decades. The relative strengths of the two wholesalers have reversed in that period, with an ascendant Sigma of the early 2000s now struggling and a genuine takeover target. This time around there are two key questions: will API be the only suitor and will the Australian Competition and Consumer Commission allow an API-Sigma merger? Marke

This content is for IR Pro subscribers only.

Subscribe now to unlock an all-access pass.

IR Pro - monthly

$5 +GST for the first 30 days. (Auto renews at $28+GST per month.)
  • Unlimited news access
  • Exclusive members only masterclasses (live and on-demand)
  • Weekly careers advice
  • Weekly and quarterly digital magazines delivered to your inbox
Subscribe now
MOST POPULAR

IR Pro - annual

$312 +GST per year. (Auto renews annually.)
  • Unlimited news access
  • Exclusive members only masterclasses (live and on-demand)
  • Weekly careers advice
  • Weekly and quarterly digital magazines delivered to your inbox
Subscribe now